Columns

EN

2026.03.07

The Current Status of Rybelsus Generic Drugs: Quality and Safety of Indian-Made Semaglutide | TASAKI PHAMA

Information on generic drugs for Rybelsus (semaglu...

Read More

EN

2026.03.07

Pantogar Import: How to Get the International Version Affordably | TASAKI PHAMA

Information regarding Pantogar import. We explain ...

Read More

EN

2026.03.07

Retatrutide Import: Potential of Retatrutide, a Next-Generation Triple Agonist, as a Research Reagent | TASAKI PHAMA

Retatrutide is a next-generation triple agonist wi...

Read More

EN

2026.03.07

Avodart (Dutasteride) Import: Current Status, Challenges, and Expanding AGA Treatment Options | TASAKI PHAMA

This article explains information regarding the im...

Read More

EN

2026.03.07

What is Orforglipron? The Latest Non-Peptide Oral GLP-1 Receptor Agonist | TASAKI PHAMA

Orforglipron is a next-generation oral GLP-1 recep...

Read More

EN

2026.03.07

What is Generic Propecia? How to Distinguish Overseas Versions from Genuine Finasteride | TASAKI PHAMA

Explains about generic drugs for Propecia. Summari...

Read More

EN

2026.03.07

Current Status and Challenges of Manjaro Importation: Precautions for Personal Importation of Overseas Pharmaceuticals | TASAKI PHAMA

Explains points to consider when contemplating the...

Read More

EN

2026.03.07

For Medical Institutions Considering Glashvista Import: Bimatoprost Ophthalmic Solution Options | TASAKI PHAMA

For medical institutions considering importing Gla...

Read More

EN

2026.03.07

Optimal Saxenda Import: Understanding Costs and Authenticity Verification | TASAKI PHAMA

We explain the precautions when importing Saxenda ...

Read More